Study on pathophysiological mechanism of autoantibody production in pemphigus
天疱疮自身抗体产生的病理生理机制研究
基本信息
- 批准号:11470185
- 负责人:
- 金额:$ 9.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mechanisms of tolerance break against desmoglein 3 (Dsg3) in patients with pemphigus vulgaris (PV) producing pathogenic anti-Dsg3 IgG autoantibodies are unclear. In this study, we had dual approaches using human materials of PV patients and a mouse model for PV.To examine cellular mechanisms underlying the autoantibody production in PV patients, we have successfully developed an Enzyme-Linked Immunospot (ELISPOT) assay which was able to detect Dsg3-specific autoimmune B cells quantitatively. The in vitro anti-Dsg3 Ab production was abolished when CD4^+ cells were depleted or when anti-HLA-DR or anti-HLA-DQ monoclonal Ab was added to the cultures, suggesting the important role of HLA class II-restricted CD4^+ T cells in the autoAb production in PV.Using a novel PV mouse model involving Dsg3 knockout mice, we investigated the mechanisms of tolerance loss against Dsg3. Adoptive transfer of Dsg3^<-/-> splenocytes immunized with recombinant mouse Dsg3 to Rag2^<-/-> recipient mice expressing Dsg3 resulted in the stable production of anti-Dsg3 IgG and development of PV phenotypes including oral erosions with suprabasilar acantholysis. When purified T and B cells from Dsg3^<-/->, Dsg3^<+/-> or Dsg3^<+/+> mice were mixed with various combinations and transferred to Rag2^<-/-> mice, pathogenic anti-Dsg3 IgG production was observed only with a combination of Dsg3^<-/-> T and Dsg3^<-/-> B cells but not with the other combinations. These results suggest that loss of tolerance against Dsg3 in both B and T cells is important for the development of autoimmune state of PV.
寻常型天疱疮(PV)患者对桥粒芯糖蛋白3(Dsg 3)的耐受性破坏机制尚不清楚,该患者产生致病性抗Dsg 3 IgG自身抗体。在这项研究中,我们有双重的方法,使用人类材料的PV患者和小鼠模型PV。为了研究细胞机制的PV患者的自身抗体的生产,我们已经成功地开发了酶联免疫斑点(ELISPOT)检测,能够定量检测Dsg 3特异性自身免疫B细胞。当去除CD 4 ^+细胞或加入抗HLA-DR或抗HLA-DQ单克隆抗体时,体外抗Dsg 3抗体的产生被消除,表明HLA II类限制性CD 4 ^+ T细胞在PV自身抗体产生中的重要作用。我们使用一种新的PV小鼠模型,包括Dsg 3基因敲除小鼠,研究了对Dsg 3耐受性丧失的机制。将用重组小鼠Dsg 3免疫的Dsg 3 ^<-/->脾细胞连续转移到表达Dsg 3的Rag 2 ^<-/->受体小鼠,导致抗Dsg 3 IgG的稳定产生和PV表型的发展,包括口腔糜烂伴基底上棘层松解。当将来自Dsg 3 ^<-/->、Dsg 3 ^<+/->或Dsg 3 ^<+/+>小鼠的纯化的T和B细胞与各种组合混合并转移至Rag 2 ^<-/->小鼠时,仅在Dsg 3 ^<-/-> T和Dsg 3 ^<-/-> B细胞的组合中观察到致病性抗Dsg 3 IgG产生,而在其它组合中未观察到。这些结果表明,在B和T细胞中对Dsg 3的耐受性的丧失对于PV的自身免疫状态的发展是重要的。
项目成果
期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Amagai M., Tsunoda K., Suzuki H., Nishifuji K., Koyasu, S., Nishikawa T.: "Use of autoantigen knockout mice to develop an active autoimmune disease model of pemphigus"J Clin Invest. 105. 625-631 (2000)
Amagai M.、Tsunoda K.、Suzuki H.、Nishifuji K.、Koyasu, S.、Nishikawa T.:“使用自身抗原敲除小鼠开发活动性天疱疮自身免疫性疾病模型”J Clin Invest。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishifuji K,Amagai M,Kuwana M,Iwasaki T,Nishikawa T: "Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot(ELISPOT)Assay:requirement of T cell collaboration for autoantibody production"J Invest Dermatol. 11
Nishifuji K、Amagai M、Kuwana M、Iwasaki T、Nishikawa T:“通过酶联免疫斑点 (ELISPOT) 检测寻常型天疱疮患者的抗原特异性 B 细胞:自身抗体产生所需的 T 细胞协作”J Invest Dermatol
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishii K,Amagai M,Komai A,et al.: "Desmoglein 1 and desmoglein 3 are the target autoanitigens in herpetiform pemphigus"Arch Dermatol. 135. 943-947 (1999)
Ishii K、Amagai M、Komai A 等人:“桥粒芯糖蛋白 1 和桥粒芯糖蛋白 3 是疱疹样天疱疮的目标自身抗原”Arch Dermatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mahoney MG, Wang Z, Rothenberger KL, Koch PJ, Amagai M, Stanley JR: "Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris" J Clin Invest. 103. 461-468 (1999)
Mahoney MG、Wang Z、Rothenberger KL、Koch PJ、Amagai M、Stanley JR:“落叶型天疱疮和寻常型天疱疮病变的临床和显微镜定位的解释”J Clin Invest。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMAGAI Masayuki其他文献
AMAGAI Masayuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMAGAI Masayuki', 18)}}的其他基金
Clarification of the molecular and cellular mechanisms of central and peripheral tolerance to pemphigus autoantigen
阐明中枢和外周天疱疮自身抗原耐受的分子和细胞机制
- 批准号:
21229014 - 财政年份:2009
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Elucidation of tolerance mechanism against peripheral target antigens in autoimmune diseases
阐明自身免疫性疾病中针对外周靶抗原的耐受机制
- 批准号:
17109012 - 财政年份:2005
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Clarification of pathophysiological mechanisms of autoimmune skin disease, pemphigus
阐明自身免疫性皮肤病、天疱疮的病理生理机制
- 批准号:
13854017 - 财政年份:2001
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Development of immune supression against gene product in gene therapy
基因治疗中针对基因产物的免疫抑制的发展
- 批准号:
11557066 - 财政年份:1999
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of disease activity monitoring assay system by ELISA using recombinant pemphigus antigens
使用重组天疱疮抗原通过 ELISA 开发疾病活动监测检测系统
- 批准号:
09670895 - 财政年份:1997
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of antigen-specific B cell elimination by recombinant toxins in autoimmune diseases
自身免疫性疾病中重组毒素消除抗原特异性 B 细胞的进展
- 批准号:
09557064 - 财政年份:1997
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
包斑蛋白与周斑蛋白抗原表位分析及其在副肿瘤性天疱疮发病中的作用
- 批准号:81130030
- 批准年份:2011
- 资助金额:260.0 万元
- 项目类别:重点项目
基于斑蛋白家族L亚区的副肿瘤性天疱疮小鼠模型的建立
- 批准号:81000694
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
桥粒芯糖蛋白 3 嵌合自身抗体受体 T 细胞 (DSG3-CAART) 对粘膜寻常型天疱疮的免疫调节作用
- 批准号:
10679911 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Phosphatase-dependent regulation of desmosome intercellular junctions
桥粒细胞间连接的磷酸酶依赖性调节
- 批准号:
10677182 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
The Variation of the NK Cell Receptome in Pemphigus
天疱疮NK细胞受体组的变异
- 批准号:
10750358 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Keratinocyte adhesion and signaling in the skin blistering disease pemphigus vulgaris
皮肤起疱病寻常型天疱疮中的角质形成细胞粘附和信号传导
- 批准号:
10732360 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Elucidation of mechanism of autoantibody production in pemphigus in conjunction with information from single cell analysis
结合单细胞分析信息阐明天疱疮自身抗体产生的机制
- 批准号:
22K08416 - 财政年份:2022
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of severity of oral mucosal lesions in paraneoplastic pemphigus using disease model mice
副肿瘤性天疱疮模型小鼠口腔黏膜病变严重程度分析
- 批准号:
22K10157 - 财政年份:2022
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel lymphocyte engineering approach for treatment of vitiligo
开发治疗白癜风的新型淋巴细胞工程方法
- 批准号:
10640098 - 财政年份:2022
- 资助金额:
$ 9.6万 - 项目类别: